share_log

Standard BioTools(LAB.US)获TD Cowen首次覆盖,给予买入评级, 目标价3.50美元。

Standard BioTools (LAB.US) was first covered by TD Cowen, which gave it a buy rating, with a target price of $3.50.

Zhitong Finance ·  Apr 16 19:20
Standard BioTools (LAB.US) was first covered by TD Cowen, which gave it a buy rating, with a target price of $3.50.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment